早期肺癌立体定向放疗肿瘤控制概率的多模型生物物理建模
该研究汇总46项已发表研究的早期非小细胞肺癌(NSCLC)立体定向放疗(SBRT)的1、2、3、5年肿瘤控制概率(TCP)数据,用六种放射生物学模型计算等中心生物有效剂量(BED)并拟合TCP。结果显示所有模型拟合均得到约20Gy的大α/β值,再生长模型拟合更优;六种模型预测α/β=20计算的BED达90Gy可实现TCP≥95%。
要点
- 所有模型拟合均显示早期NSCLC的SBRT的α/β约为20Gy。
- 再生长模型(考虑肿瘤再增殖与异质性)对临床数据拟合优于其他五种模型。
- 六种模型预测α/β=20计算的BED为90Gy足以达到TCP≥95%。
核心结论
- 早期NSCLC的SBRT局部TCP强烈依赖BED,α/β约为20Gy。
- 六种模型预测α/β=20计算的BED为90Gy足以实现TCP≥95%。
- 再生长模型对临床数据的拟合优于其他五种模型。
研究设计与样本
- 汇总46项已发表研究的早期NSCLC的SBRT的1、2、3、5年TCP数据,尽可能区分T1与T2。
- 用六种放射生物学模型在等中心计算BED,并以最小χ2法拟合TCP数据确定模型参数。
主要发现
- 所有模型拟合均得出一致的大α/β值,约为20Gy。
- 再生长模型较其他五种模型对数据拟合更好,其余五种模型间拟合难以区分。
- 基于拟合参数的模型预测T2肿瘤较T1每分次需额外约1Gy物理剂量(分次≤5)以达到最优TCP。
关键数值与推荐
- α/β=20Gy计算的BED为90Gy对应TCP≥95%。
- T2较T1每分次需额外约1Gy物理剂量(分次≤5)。
临床怎么用
- 可参考α/β=20Gy计算BED评估早期NSCLC的SBRT剂量效应。
- BED(α/β=20)达90Gy可作为追求TCP≥95%的剂量参考。
- T2肿瘤可能需要每分次约增加1Gy物理剂量(分次≤5)以达到与T1相近的TCP。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This work is to analyze pooled clinical data using different radiobiological models and to understand the relationship between biologically effective dose (BED) and tumor control probability (TCP) for stereotactic body radiotherapy (SBRT) of early-stage non-small cell lung cancer (NSCLC). The clinical data of 1-, 2-, 3-, and 5-year actuarial or Kaplan-Meier TCP from 46 selected studies were collected for SBRT of NSCLC in the literature. The TCP data were separated for Stage T1 and T2 tumors if possible, otherwise collected for combined stages. BED was calculated at isocenters using six radiobiological models. For each model, the independent model parameters were determined from a fit to the TCP data using the least chi-square (χ2) method with either one set of parameters regardless of tumor stages or two sets for T1 and T2 tumors separately. The fits to the clinic data yield consistent results of large α/β ratios of about 20Gy for all models investigated. The regrowth model that accounts for the tumor repopulation and heterogeneity leads to a better fit to the data, compared to other 5 models where the fits were indistinguishable between the models. The models based on the fitting parameters predict that the T2 tumors require about additional 1Gy physical dose at isocenters per fraction (⩽5 fractions) to achieve the optimal TCP when compared to the T1 tumors. In conclusion, this systematic analysis of a large set of published clinical data using different radiobiological models shows that local TCP for SBRT of early-stage NSCLC has strong dependence on BED with large α/β ratios of about 20Gy. The six models predict that a BED (calculated with α/β of 20) of 90Gy is sufficient to achieve TCP⩾95%. Among the models considered, the regrowth model leads to a better fit to the clinical data.
引用
- Liu F, Tai A, Lee P, et al. Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. Radiother Oncol. 2016. PMID: 27871671. doi:10.1016/j.radonc.2016.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。